41128 Federal Register / Vol. 87, No. 131 / Monday, July 11, 2022 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women (ACBCYW) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Advisory Committee on Breast 

Cancer in Young Women (ACBCYW). 

This meeting is open to the public, 

limited only by the number of audio and 

web conference lines (100 audio and 

web conference lines are available). 

Online registration is required. 

DATES: The meeting will be held on 

August 23, 2022, from 11:00 a.m. to 4:00 

p.m., EDT. 

ADDRESSES: All meeting participants 

must register online for the meeting at 

least 2 business days in advance at 

https://www.cdc.gov/cancer/breast/ 

what_cdc_is_doing/meetings.htm. 

Please complete all the required fields 

and submit your registration no later 

than August 19, 2022. Registered 

participants will receive the audio and 

web conference access instructions 

before the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly E. Smith, MBA, MHA, 

Designated Federal Officer, National 

Center for Chronic Disease Prevention 

and Health Promotion, CDC, 4770 

Buford Highway NE, Mailstop S107–4, 

Atlanta, Georgia 30341; Telephone (404) 

498–0073; Fax (770) 488–4760; Email: 

acbcyw@cdc.gov. 

SUPPLEMENTARY INFORMATION:

Purpose: The committee provides 

advice and guidance to the Secretary, 

HHS; the Assistant Secretary for Health; 

and the Director, CDC, regarding the 

formative research, development, 

implementation, and evaluation of 

evidence-based activities designed to 

prevent breast cancer (particularly 

among those at heightened risk) and 

promote the early detection and support 

of young women who develop the 

disease. The advice provided by the 

Committee will assist in ensuring 

scientific quality, timeliness, utility, and 

dissemination of credible appropriate 

messages and resource materials. 

Matters to be Considered: The agenda 

will include discussions on current 

topics related to breast cancer in young 

women. These will include Mental/ 

Behavioral Health, Sexual Health, 

Genetics and Genomics, and Provider 

Engagement. Agenda items are subject 

to change as priorities dictate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–14712 Filed 7–8–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0062] 

Advisory Committee on Immunization 

Practices (ACIP); Amended Notice of 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. 

DATES: The meeting will be held on June 

22, 2022, from 10:00 a.m. to 5:10 p.m., 

EDT, and June 23, 2022, from 10:00 a.m. 

to 5:00 p.m., EDT (times subject to 

change). The docket is currently open to 

receive written comments. Written 

comments must be received on or before 

June 23, 2022. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Advisory Committee on 

Immunization Practices (ACIP); June 22, 

2022, from 10:00 a.m. to 5:00 p.m., EDT, 

and June 23, 2022, from 10:00 a.m. to 

2:00 p.m., EDT (times subject to 

change), in the original Federal Register 

notice. 

The virtual meeting was published in 

the Federal Register on Tuesday, May 

10, 2022, Volume 87, Number 90, pages 

28013–28014. 

The virtual meeting is being amended 

to change the times to June 22, 2022, 

from 10:00 a.m. to 5:10 p.m., EDT, and 

June 23, 2022, from 10:00 a.m. to 5:00 

p.m., EDT (times subject to change), and 

to update the matters to be considered, 

which should read as follows: 

Matters To Be Considered: The agenda 

will include discussions on influenza 

vaccine; pneumococcal vaccines; 

measles, mumps, rubella (MMR) 

vaccine; COVID–19 vaccines; 

meningococcal vaccines; respiratory 

syncytial virus vaccine; Chikungunya 

vaccines; and human papillomavirus 

vaccine. Recommendation votes on 

influenza vaccine, pneumococcal 

vaccine, MMR vaccine, and the use of 

Moderna COVID–19 vaccine in children 

ages 6 through 17 years are scheduled. 

A Vaccines for Children vote(s) is 

scheduled on pneumococcal vaccine 

and is possible on MMR vaccine. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP, visit the ACIP 

website: https://www.cdc.gov/vaccines/ 

acip/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, Mailstop H24–8, Atlanta, Georgia 

30329–4027; Telephone: 404–639–8367; 

Email: ACIP@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–14713 Filed 7–8–22; 8:45 am] 

BILLING CODE 4163–18–P 


khammond on DSKJM1Z7X2PROD with NOTICES